Fintel reports that on September 3, 2026, JP Morgan upgraded their outlook for Envista Holdings (NYSE:NVST) from Neutral to Overweight. Prior to this upgrade, JP Morgan maintained a Neutral rating on Envista Holdings, with the last action recorded on May 7, 2026. Additionally, on August 6, 2026, Piper Sandler reiterated its Neutral rating for the company.
Envista Holdings Corporation, based in the United States, operates primarily in the dental products and technologies sector. The company provides a comprehensive range of products and solutions that cater to dental professionals, including dental implants, orthodontics, and digital imaging technologies. A significant aspect of Envista’s operations includes its focus on digital innovations with DEXIS imaging solutions and the Nobel Biocare implant systems, aiming to enhance diagnostics and treatment planning in dentistry.
On September 2, 2026, the day before the rating action, Envista Holdings closed at $27.39. On September 3, 2026, the stock closed at $27.59. Looking at recent trends, the stock experienced a price change of +0.55% over one week, compared to a baseline close of $27.44 on August 27, 2026. Over a one-month period, the price change was +0.80% from a baseline close of $27.37 on August 3, 2026.
As of August 30, 2026, the current consensus target mean for Envista Holdings was $31.32, with a median target of $31.62. This mean target represents an implied change of +13.53% from previous levels. The prior consensus target mean was $30.13 as of August 5, 2026, reflecting a consensus target revision of +3.96%. In terms of broader analyst recommendations, as of September 1, 2026, the current recommendation breakdown consisted of 7 strong buy, 5 buy, 10 hold, 0 sell, and 0 strong sell recommendations, totaling 22 recommendations. This represents 54.5% positive, 45.5% hold, and 0.0% negative recommendations, which remained unchanged from the prior recommendation period on August 1, 2026.
Envista Holdings reported its latest earnings on August 5, 2026. The actual earnings per share (EPS) was 0.41, exceeding the estimated EPS of 0.3419, which represents a surprise of +19.92%. The actual revenue was reported as $730,500,000,000,000.00, compared to an estimated revenue of $730,371,948,000,000.00. According to the company’s Form EX-99.1 filing dated August 5, 2026, titled “ENVISTA HOLDINGS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)”, the company reported non-GAAP adjusted gross profit of $402.2 million and adjusted operating profit of $94.5 million for the three months ended July 3, 2026. Adjusted net income for the same period was $66.5 million, with adjusted diluted EPS of $0.41 and adjusted EBITDA of $107.7 million. Free cash flow was reported at $105.1 million. The company also filed a Form 10-Q on August 5, 2026, for the quarterly period ended July 3, 2026.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| September 3, 2026 | JP Morgan | Neutral | Overweight | upgrade |
| August 6, 2026 | Piper Sandler | Neutral | Neutral | reiterated |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
